CD30 ligand is frequently expressed in human hematopoietic malignancies of myeloid and lymphoid origin

Blood

Volumn 89, Issue 6, 1997, Pages 2048-2059

  Gattei, Valter ^a   Degan, Massimo ^b   Gloghini, Annunziata ^b   De Luliis, Angela ^b   Improta, Salvatore ^b   Rossi, Francesca Maria ^b   Aldinucci, Donatella ^b   Perin, Vilma ^b   Serraino, Diego ^b   Babare, Roberta ^b   Zagonel, Vittorina ^b   Gruss, Hans Jürgen ^b   Carbone, Antonino ^b   Pinto, Antonio ^b  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD30 ANTIGEN; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2 RECEPTOR; MEMBRANE PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; B CELL LYMPHOMA; HAIRY CELL LEUKEMIA; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROLYMPHOCYTIC LEUKEMIA; PROTEIN EXPRESSION; T CELL LEUKEMIA; T CELL LYMPHOMA;

EID: 0030933621     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.6.2048     Document Type: Article

References (66)

1. Bradstock KF, Gottlieb DJ: Interaction of acute leukemia cells with the bone marrow microenvironment: Implications for control of minimal residual disease. Leuk Lymphoma 18:1, 1995
2. Alien TD, Dexter TM: The essential cells of the hematopoietic microenvironment. Exp Hematol 12:517, 1984
3. Dorshkind K: Regulation of hematopoiesis by bone marrow stromal cells and their products. Annu Rev Immunol 8:111, 1990
4. Manabe A, Gopal Murti K, Coustan-Smith E, Kumagai M, Behm FG, Raimondi SC, Gampana D: Adhesion-dependent survival of normal and leukemic human B-lymphoblasts on bone marrow stromal cells. Blood 83:758, 1994
5. Russell NH, Hunter AE, Bradbury D, Zhu YM, Keith F: Biologicai features of leukemic cells associated with autonomous growth and reduced survival in acute myeloblastic leukemia. Leuk Lymphoma 16:223, 1995
6. Budel LM, Touw I, Delwel R, Clark SC, Lowenberg B: Interleukin-3 and granulocyte-macrophage colony-stimulating factor receptors on human acute myelocytic leukemia cells and relationship to proliferative response. Blood 74:565, 1989
7. Bradbury D, Rogers S, Reilly IAG, Kozlowsky R, Russel NH: Role of autocrine and paracrine production of granulocyte-macrophage colony-stimulating factor and interleukin-1β in the autonomous growth of acute myeloblastic leukemia cells - Studies using purified CD34-positive cells. Leukemia 6:562, 1992
8. Cross M, Dexter TM: Growth factors in development, transformation and tumorigenesis. Cell 64:271, 1991
9. Pinto A, Gattei V, Soligo D, Parravicini C, Del Vecchio L: New molecules burst at the leukocyte surface. A comprehensive review based on the 5th International Workshop on Leukocyte Differentiation Antigens. Leukemia 8:347, 1994
10. Long MW: Blood cell cytoadhesion molecules. Exp Hematol 20:288, 1992
11. Ruosiathi E, Reed J: Anchorage dependence, integrins and apoptosis. Cell 77:477, 1994
12. Reilly IAG, Kozslowsky R, Russell NH: The role of cell contact and autostimulating soluble factors in the proliferation of blast cells in acute myeloblastic leukemia. Leukemia 3:145, 1988
13. Takashita E, Sugimoto K, Adachi Y, Mori KJ: Induction of bcl-2 gene expression by intracellular information from hemopoietic supportive stromal cells to DA-1 cells. J Cell Physiol 161:363, 1994
14. Massagué J, Pandiella A: Membrane-anchored growth factors. Annu Rev Biochem 62:515, 1993
15. van der Geer P, Hunter T, Lindberg RA: Receptor protein-tyrosine kinases and their signal transduction pathways. Annu Rev Cell Biol 10:251, 1994
16. Galli SJ, Zsebo KM, Geissler EN: The kit ligand, stem cell factor. Adv Immunol 55:1, 1994
17. Smith CA, Farrah T, Goodwin RC: The TNF receptor superfamily of cellular and viral protein: Activation, costimulation and death. Cell 76:959, 1994
18. Armitage RJ: Tumor necrosis factor receptor superfamily members and their ligands. Curr Opin Immunol 6:407, 1994
19. Gruss H-J, Dower SK: TNF ligand superfamily: Involvement in the pathology of malignant lymphomas. Blood 85:3378, 1995
20. Wiley SR, Schooley K, Smolak PG, Din WS, Huang CP, Micholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA, Goodwin RG: Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673, 1995
21. Smith CA, Gruss H-J, Davis T, Anderson D, Anderson D, Farrah T, Baker E, Sutherland GR, Brannan CI, Copeland NG, Jenkins NA, Grabstein KH, Gliniak B, McAlister IB, Fanslow W, Alderson M, Falk B, Gimpel S, Gillis S, Din SW, Goodwin RG, Armitage RJ: CD30 antigen, a marker for Hodgkin's lymphoma is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 73:1349, 1993
22. Dürkop H, Latza U, Hummel M, Eithelbach F, Seed B, Stein H: Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 68:421, 1992
23. Falini B, Pileri S, Pizzolo G, Durkop H, Flenghi L, Stirpe F, Martelli MF, Stein H: CD30 (Ki-1) molecule: A new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood 85:1, 1995
24. Gruss H-J, Boiani N, Williams DE, Armitage RJ, Smith CA, Goodwin RG: Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines. Blood 83:2045, 1994
25. Gruss H-J, Da Silva N, Hu Z-B, Uphoff CC, Goodwin RG, Drexler HG: Expression and regulation of CD30 ligand and CD30 in human leukemia-lymphoma cell lines. Leukemia 8:2083, 1994
26. 26: Gruss H-J, Pinto A, Gloghini A, Wehnes E, Wright B, Boiani N, Aldinucci D, Gattei V, Zagonel V, Smith GA, Kadin ME, von Schilling C, Goodwin RG, Herrmann F, Carbone A: CD30 ligand expression in normal, reactive and Hodgkin's disease-involved lymph nodes. Am J Pathol 149:469, 1996
27. Gruss H-J, Hirschstein D, Alderson MR, Herrmann F, Armitage RJ: Regulation of CD30 ligand expression on peripheral blood T cells: Possible functional involvement in T-T cell interaction. J Immunol (in press)
28. Pinto A, Aldinucci D, Gloghini A, Zagonel V, Degan M, Improta S, Juzbasic S, Todesco M, Perin V, Gattei V, Herrmann F, Gruss H-J, Carbone A: Human eosinophils express functional CD30 ligand and stimulate proliferation of a Hodgkin's disease cell line. Blood 88:3299, 1996
29. Gruss H-J, Ulrich D, Braddy S, Armitage R, Dower SK: Recombinant CD30 ligand and CD40 ligand share common biological activities on Hodgkin and Reed-Sternberg cells. Eur J Immunol 25:2083, 1995
30. Gruss H-J, Scheffrahn I, Hübinger G, Duyster J, Herrmann F: The CD30 ligand and CD40 ligand regulate CD54 surface expression and release of its soluble form by cultured Hodgkin and Reed-Sternberg cells. Leukemia 10:829, 1996
31. Ellis TM, Simms PE, Slivink DJ, Jack H-M, Fisher RI: CD30 is a signal-transducing molecule that defines a subset of human activated CD45RO+ T cells. J Immunol 151:2380, 1993
32. Alzona M, Jäck H-M, Fisher R, Ellis TM: CD30 defines a subset of activated human T cells that produce IFN-γ and IL-5 and exhibit enhanced B cell helper activity. J Immunol 153:2867, 1994
33. Del Prete GF, De Carli M, Almerigogna F, Daniel CK, D'elios MM, Zancuoghi G, Pizzolo G, Romagnani S: Preferential expression of CD30 by human CD4+ T-cells producing Th2-type cytokines. FASEB J 9:81, 1995
34. Hamann D, Hilkens CMU, Grogan JL, Lens SMA, Kapsenberg ML, Yazdanbakhsh M, van Lier RAW: CD30 expression does not discriminate between human Th1 - and Th2-type T cells. J Immunol 156:1387, 1996
35. Gruss H-J, Hermann F, Drexler HG: Hodgkin's disease: A cytokine producing tumor. Crit Rev Oncog 5:23, 1994
36. French-American-British (FAB) Cooperative Group: Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med 103:626, 1985
37. Rothe G, Schmitz G, for The Working Group on Flow Cytometry and Image Analysis: Consensus protocol for the flow cytometry immunophenotyping of hematopoietic malignancies. Leukemia 10:877, 1996
38. The Non-Hodgkin's Lymphoma Pathologic Classification Project: National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas. Summary and description of a Working Formulation for clinical usage. Cancer 42:2112, 1982
39. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hemerlink HK, Pileri S, Pins MA, Ralfkiaer E, Warnke RA: A revised European American classification of lymphoid neoplasms: A proposal from The International Lymphoma Study Group. Blood 84:1361, 1994
40. Carbone A, Gloghini A, Zagonel V, Aldinucci D, Gattei V, Degan M, Improta S, Sorio R, Monfardini S, Pinto A: The expression of CD26 and CD40 ligand is mutually exclusive in human T-cell non-Hodgkin's lymphomas/leukemias. Blood 86:4617, 1995
41. Manfioletti G, Gattei V, Buratti E, Rustighi A, De Iuliis A, Aldinucci D, Goodwin GH, Pinto A: Differential expression of a novel proline-rich homeobox gene (Prh) in human hematolymphopoietic cells. Blood 85:1237, 1995
42. van Zaanen HCT, Vet RJWM, de Jong CM, von dem Borne AEGKr, van Oers MHJ: A simple and sensitive method for determining plasma cell isotype and monoclonality in bone marrow using flowcytometry Br J Haematol 91:55, 1995
43. Carbone A, Gloghini A, Gattei V, Aldinucci D, Degan M, De Paoli P, Zagonel V, Pinto A: Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines. Blood 85:780, 1995
44. Chomczynsky P, Sacchi N: Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
45. Armitage P, Berry G: Statistical Methods in Medical Research. London, UK, Blackwell Scientific, 1987
46. Craig W, Kay R, Cutler RL, Landsorp PM: Expression of Thy-1 on human hemopoietic progenitor cells. J Exp Med 177:1331, 1993
47. + acute leukemia. Blood 86:60, 1995
48. Schumann RR, Nakarai T, Gruss H-J, Brach M, von Arnim U, Kirschning C, Karawajew L, Ludwig W-D, Renauld J-C, Ritz J, Herrmann F: Transcript synthesis and surface expression of the interleukin-2 receptor (α-, β-, γ-chain) by normal and malignant myeloid cells. Blood 87:2419, 1996
49. Nakase K, Kita K, Otsuji A, Anazawa H, Oshino K, Sekine T, Shirakawa S, Tanaka I, Nasu K, Tsutani H, Dohy H, Tsudo M: Diagnostic and clinical importance of interleukin-2 receptor alpha chain expression on non-T-cell acute leukaemia cells. Br J Haematol 80:317, 1992
50. Maio M, Pinto A, Carbone A, Zagonel V, Gloghini A, Puozza J, Cirillo D, Colombacci A, Ferrara F, Del Vecchio L, Ferrone S: Differential expression of CD54/Intercellular adhesion molecule-1 in myeloid leukemias and lymphoproliferative disorders. Blood 76:783, 1990
51. Pui CH, Raimondi SC, Head DR, Schell MJ, Rivera GK, Mirro J Jr, Crist WM, Behm FG: Characterization of childhood acute leukemia with multiple myeloid and lymphoid markers at diagnosis and at relapse. Blood 78:1327, 1991
52. Freedman AS: Cell surface antigens in leukemias and lymphomas. Cancer Invest 14:252, 1996
53. Younes A, Consoli U, Zhao S, Snell V, Thomas E, Gruss H-J, Cabanillas F, Andreeff M: CD30 ligand is expressed on resting normal and malignant human B lymphocytes. Br J Haematol 93:569, 1966
54. Del Prete G, Maggi E, Pizzolo G, Romagnani S: CD30, Th2 cytokines and HIV infection: A complex and fascinating link. Immunol Today 16:76, 1995
55. Stein H, Mason DY, Gerdes J, O'Connor N, Wainscoat J, Pallesen G, Gatter K, Falini B, Delsol G, Lemke H, Schwarting R, Lennert K: The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66:848, 1985
56. Chilosi M, Facchetti F, Notarangelo LD, Romagnani S, Del Prete G, Almerigogna F, De Carli M, Pizzolo G: CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome: Evidence for a T helper 2-mediated condition. Eur J Immunol 26:329, 1996
57. Rohde D, Hansen H, Hafner M, Lange H, Mielke V, Hansmann M-L, Lemke H: Cellular localizations and processing of the two molecular forms of the Hodgkin-associated Ki-1 (CD30) antigen. Am J Pathol 140:473, 1992
58. Fickers M, Theunissen P: Granulocytic sarcoma with expression of CD30. J Clin Pathol 49:762, 1996
59. Bowen MA, Lee RK, Miragliotta G, Nam SY, Podack ER: Structure and expression of murine CD30 and its role in cytokine production. J Immunol 156:442, 1996
60. McDonald PP, Cassatella MA, Bald A, Maggi E, Romagnani S, Gross H-J, Pizzolo G: CD30 ligation induces nuclear factor-κB activation in human T cell lines. Eur J Immunol 25:2870, 1995
61. Gruss H-J, Ulrich D, Dower SK, Herrmann F, Brach M: Activation of Hodgkin cells via the CD30 receptor induces autocrine secretion of interleukin-6 engaging the NF-κB transcription factor. Blood 87:2443, 1996
62. Amakawa R, Hakem A, Kundig TM, Matsuyama T, Simard JJL, Timms E, Wakeham A, Mittruecker H-W, Griesser H, Takimoto H, Schmits R, Shahinian A, Ohashi PS, Penniger JM, Mak TW: Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice. Cell 84:551, 1996
63. Lee SY, Park CG, Choi Y: T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors. J Exp Med 183:669, 1996
64. Mosmann TR, Sad S: The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17:138, 1996
65. Manetti R, Annunziato F, Biagiotti R, Giudizi MG, Piccini MP, Giannarini L, Sampognaro S, Parronchi P, Vinante F, Pizzolo G, Maggi E, Romagnani S: CD30 expression by CD8+ T cells producing type 2 helper cytokines. Evidence for large numbers of CD8+ CD30+ T cell clones in human immunodeficiency virus infection. J Exp Med 180:2407, 1994
66. van der Horst FAL, van der Marel A, den Ottolander GJ, Kluin-Nelemans HC: Decrease of memory T helper cells (CD4+ CD45R0+) in hairy cell leukemia. Leukemia 7:46, 1993